BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/1/2015 11:51:00 AM | Browse: 1314 | Download: 1927
 |
Received |
|
2014-08-19 16:57 |
|
Peer-Review Started |
|
2014-08-20 15:40 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-10-11 11:57 |
|
Revised |
|
2014-11-06 22:09 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-12-16 15:30 |
|
Second Decision by Editor-in-Chief |
|
2014-12-17 03:30 |
|
Final Decision by Editorial Office Director |
|
2014-12-22 17:09 |
|
Articles in Press |
|
2014-12-22 17:30 |
|
Edit the Manuscript by Language Editor |
|
2015-01-21 04:28 |
|
Typeset the Manuscript |
|
2015-02-08 18:00 |
|
Publish the Manuscript Online |
|
2015-02-28 17:07 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Clinical Trials Study |
| Article Title |
Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Bing Xia, Le Zhang, Shan-Qi Guo, Xiao-Wu Li, Fu-Lian Qu, Hai-Feng Zhao, Lian-Yu Zhang, Bao-Cun Sun, James You and Yi-Zhuo Zhang |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
30672208 |
| National Natural Science Foundation of China |
81270603 |
| National Natural Science Foundation of China |
31301161 |
| Tianjin Natural Science Foundation of China |
13JCYBJC22800 |
|
| Corresponding Author |
Yi-Zhuo Zhang, Professor, Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China. yizhuozhang111@163.com |
| Key Words |
MYC; BCL-2; Survival; Primary gastrointestinal diffuse large B-cell lymphoma; Prognosis |
| Core Tip |
We investigated MYC and BCL-2 coexpression in primary gastrointestinal diffuse large B-cell lymphoma (PGI-DLBCL) and explored its associations with patients’ clinical parameters. In contrast to previously published results about MYC/BCL-2 coexpression in DLBCL, this study focused on PGI-DLBCL. Although PGI-DLBCL is rare, we had a large collection of 60 PGI-DLBCL cases to test the protein and mRNA levels of MYC and BCL-2. We found that MYC+/BCL-2+ patients have worse chemotherapy response and poorer prognosis than patients who only express one of the two proteins, suggesting that assessment of MYC and BCL-2 expression has clinical significance in predicting clinical outcomes of PGI-DLBCL patients. |
| Publish Date |
2015-02-28 17:07 |
| Citation |
Xia B, Zhang L, Guo SQ, Li XW, Qu FL, Zhao HF, Zhang LY, Sun BC, You J, Zhang YZ. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma. World J Gastroenterol 2015; 21(8): 2433-2442 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i8/2433.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i8.2433 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
